These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29749702)

  • 1. Management of severe chronic pain with methadone in pediatric patients with sickle cell disease.
    LeBlanc Z; Vance C; Payne J; Zhang J; Hilliard L; Lebensburger JD; Howard TH
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27084. PubMed ID: 29749702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid treatment for acute and chronic pain in patients with sickle cell disease.
    Carroll CP
    Neurosci Lett; 2020 Jan; 714():134534. PubMed ID: 31593753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Chronic Pain in Adults Living With Sickle Cell Disease in the Era of the Opioid Epidemic: A Qualitative Study.
    Sinha CB; Bakshi N; Ross D; Krishnamurti L
    JAMA Netw Open; 2019 May; 2(5):e194410. PubMed ID: 31125105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tapering and discontinuation of methadone for chronic pain.
    Breivik H
    J Pain Palliat Care Pharmacother; 2015 Jun; 29(2):185-6. PubMed ID: 26095495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Perioperative Management Considerations in Patients Taking Methadone.
    Cornett EM; Kline RJ; Robichaux SL; Green JB; Anyama BC; Gennuso SA; Okereke EC; Kaye AD
    Curr Pain Headache Rep; 2019 Jun; 23(7):49. PubMed ID: 31209656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Pain Does Not Impact Baseline Circulating Cytokine Levels in Adults with Sickle Cell Disease.
    Karafin MS; Simpson P; Field JJ
    Acta Haematol; 2021; 144(1):111-116. PubMed ID: 32403100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial and pharmacological management of pain in pediatric sickle cell disease.
    Hildenbrand AK; Nicholls EG; Daly BP; Marsac ML; Tarazi R; Deepti R
    Postgrad Med; 2014 Mar; 126(2):123-33. PubMed ID: 24685976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pain in sickle cell disease: current and potential translational therapies.
    Sagi V; Mittal A; Tran H; Gupta K
    Transl Res; 2021 Aug; 234():141-158. PubMed ID: 33711512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and analgesic effects of methadone in children and adults with sickle cell disease.
    Horst J; Frei-Jones M; Deych E; Shannon W; Kharasch ED
    Pediatr Blood Cancer; 2016 Dec; 63(12):2123-2130. PubMed ID: 27572136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving Quality of Care for Sickle Cell Patients in the Pediatric Emergency Department.
    Lin SM; Strouse JJ; Whiteman LN; Anders J; Stewart RW
    Pediatr Emerg Care; 2016 Jan; 32(1):14-6. PubMed ID: 25834959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine for the treatment of pain in sickle cell disease.
    Gupta M; Msambichaka L; Ballas SK; Gupta K
    ScientificWorldJournal; 2015; 2015():540154. PubMed ID: 25654130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comprehensive Review of the Treatment and Management of Pain in Sickle Cell Disease.
    Fiocchi J; Urits I; Orhurhu V; Orhurhu MS; Giacomazzi S; Hoyt B; Kaye AD; Kaye RJ; Viswanath O
    Curr Pain Headache Rep; 2020 Mar; 24(5):17. PubMed ID: 32200490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buprenorphine for Chronic Pain in a Pediatric Patient With Sickle-Cell Disease.
    Irwin M; Gunther W; Keefer P; Saul D; Singh SA; Wright J; Smith MA
    J Pain Symptom Manage; 2021 Nov; 62(5):1086-1091. PubMed ID: 33864846
    [No Abstract]   [Full Text] [Related]  

  • 14. Methadone for Pain Management in Children with Cancer.
    Habashy C; Springer E; Hall EA; Anghelescu DL
    Paediatr Drugs; 2018 Oct; 20(5):409-416. PubMed ID: 30047027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid utilization patterns in United States individuals with sickle cell disease.
    Ballas SK; Kanter J; Agodoa I; Howard R; Wade S; Noxon V; Dampier C
    Am J Hematol; 2018 Oct; 93(10):E345-E347. PubMed ID: 30051929
    [No Abstract]   [Full Text] [Related]  

  • 16. Ketamine Infusion for Pain Control in Acute Pediatric Sickle Cell Painful Crises.
    Hagedorn JM; Monico EC
    Pediatr Emerg Care; 2019 Jan; 35(1):78-79. PubMed ID: 27902670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.
    Puri L; Nottage KA; Hankins JS; Anghelescu DL
    Paediatr Drugs; 2018 Feb; 20(1):29-42. PubMed ID: 28853040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting novel mechanisms of pain in sickle cell disease.
    Tran H; Gupta M; Gupta K
    Blood; 2017 Nov; 130(22):2377-2385. PubMed ID: 29187376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone for Pain Management: A Pharmacotherapeutic Review.
    Kreutzwiser D; Tawfic QA
    CNS Drugs; 2020 Aug; 34(8):827-839. PubMed ID: 32564328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient characteristics affect the response to ketamine and opioids during the treatment of vaso-occlusive episode-related pain in sickle cell disease.
    Nobrega R; Sheehy KA; Lippold C; Rice AL; Finkel JC; Quezado ZMN
    Pediatr Res; 2018 Feb; 83(2):445-454. PubMed ID: 28902183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.